hydralazine (high-dose)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for hydralazine (high-dose), covering 2022-01-06 to 2022-01-06. Get the full timeline:
Most recent: Clinical Trial Update: The Prognostic Impact of Using High-dose Hydralazine in Severe Systolic Heart Failure With Hemodynamically Significant Mitral Regurgitation [Phase 4]